Fully Loaded

Areas of Interest
  • Identification of emergent genomic alterations of interest due to increased testing and population analysis
  • Identification of emergent genomic alterations of interest due to increased testing and population analysis
  • Identification of emergent genomic alterations of interest due to increased testing and population analysis

If you are interested in collaborating to advance the general understanding and clinical relevance of genomic testing for cancer, we would love to hear from you.

Get in touch today at info@elevationoncology.com

Industry Highlights

Learn more about what industry leaders are saying about genomic testing for cancer

“Precise therapy development is needed to ensure that patients and their physicians have treatment options that make their genomic test results actionable.

Dr. Lori Kunkel, Chair of the Scientific Advisory Board
Talk to your doctor about getting tested today

We believe that genomic testing is critical to ensuring that patients receive their best chance at improved outcomes. Knowing whether your tumor has a driver mutation can help your doctor best guide your treatment plans.

Ask your doctor today about your options for genomic testing, and whether you may be eligible for an approved targeted therapy or a clinical trial. Here are a few downloadable resources to help you start the discussion.

We hope that our experiences can inspire and support others embarking on a similar drug development journey.

While each driver alteration may individually be rare, our combined efforts as part of a vibrant precision medicine community can enable a future where every patient’s cancer genomic test results in an actionable treatment decision.

This is a subtitle

This is title

Some content can go here.

  • This field is for validation purposes and should be left unchanged.